
51 - 200 employees
đ§Ź Biotechnology
đ Pharmaceuticals
đĽ Funding within the last year
đ° $500M Post-IPO Debt - Celcuity on 2025-09
Biotechnology ⢠Pharmaceuticals
Celcuity is a clinical-stage biotechnology company developing targeted therapies that comprehensively block the PI3K/AKT/mTOR (PAM) pathway to treat multiple solid tumors. Its lead product candidate, gedatolisib, is a potential first-in-class pan-PI3K and mTORC1/2 inhibitor in late-stage clinical development (including Phase 3 VIKTORIA trials) for HR+/HER2- advanced breast cancer and other indications such as prostate cancer. The company advances a focused pipeline of PAM pathway inhibitors, publishes clinical data, engages with investors and regulators, and is mission-driven to improve outcomes for cancer patients.
đ Yesterday
Improve your chances of getting an interview by checking your resume score before you apply.

51 - 200 employees
đ§Ź Biotechnology
đ Pharmaceuticals
đĽ Funding within the last year
đ° $500M Post-IPO Debt - Celcuity on 2025-09
Biotechnology ⢠Pharmaceuticals
Celcuity is a clinical-stage biotechnology company developing targeted therapies that comprehensively block the PI3K/AKT/mTOR (PAM) pathway to treat multiple solid tumors. Its lead product candidate, gedatolisib, is a potential first-in-class pan-PI3K and mTORC1/2 inhibitor in late-stage clinical development (including Phase 3 VIKTORIA trials) for HR+/HER2- advanced breast cancer and other indications such as prostate cancer. The company advances a focused pipeline of PAM pathway inhibitors, publishes clinical data, engages with investors and regulators, and is mission-driven to improve outcomes for cancer patients.
⢠Lead projects to support development of novel and existing formulations, spanning the product lifecycle including pre-formulation, dosage form selection, formulation development, process development, and manufacturing scale-up. ⢠Design, execute, and interpret formulation and process development experiments in an outsourced environment at contract laboratories and CDMOs. ⢠Identify and vet new contract organizations to support formulation and process development. ⢠Help define & execute the project plans for formulation lifecycle management. ⢠Support writing technical sections for intellectual property and regulatory filings. ⢠Develop and maintain an in-depth knowledge of formulation development trends, techniques, and technologies. ⢠Serve as a subject matter expert for formulation development within the Pharmaceutical Development group and the broader Celcuity team. ⢠Summarize, document, and present information to subgroup, group, and cross-functional audiences. ⢠Other duties as assigned.
⢠Ph.D/M.S./B.S. in Pharmaceutical Science, Chemical Engineering, Chemistry, Biochemistry, Biochemical Engineering, or related fields. ⢠7+ years of experience in pharmaceutical development (preferred 4+ years industry experience for Ph.D; 5+ years for M.S.; 7+ years for B.S.). ⢠Demonstrated experience with formulation development and drug product development, preferably for small molecule drugs. ⢠Deep understanding of formulation techniques & considerations for sterile, parenteral dosage forms. Knowledge of other dosage forms (e.g., for ophthalmic or oral) is beneficial. ⢠Experience with drug device combination products for injectable drug products (e.g., prefilled syringes, autoinjectors) is preferred. Knowledge of other dosage form delivery techniques (e.g., for ophthalmic) is beneficial. ⢠Technical expertise in formulation strategies and processes specifically tailored to poorly water-soluble APIs is preferred. Subject matter expertise in one or more of these areas is highly desirable: Nano-milling and nanosuspension formulation, Micro/nano-emulsions, Salt formation and salt screening/selection, Complexation and co-solvency using cyclodextrins or co-solvents, Lyophilization. ⢠Experience with physicochemical characterization methods for drug substances and drug products. ⢠Excellent written and verbal communication skills, with ability to influence and build credibility at all levels. ⢠Strong interpersonal skills for interacting with colleagues across various levels and functions. ⢠Attention to detail and ability to manage multiple processes and documentation requirements. ⢠Strong technical and analytical skills with advanced knowledge in MS Office products. ⢠Ability to work in a team or independently as required. ⢠Outstanding organizational skills with the ability to prioritize. ⢠Demonstrated independent and sound decision-making skills; ability to think critically and make decisions in a fast-paced environment. ⢠Flexible and willing to learn; able to adapt to business and site needs in a dynamic environment. ⢠Maintain a positive, approachable and professional attitude.
⢠Medical, dental, and vision insurance ⢠401(k) match ⢠PTO ⢠Paid holidays ⢠Eligible for an annual performance incentive bonus ⢠New hire equity package
Apply Nowđ Yesterday
10,000+ employees
Health Scientist â Senior Associate supporting federal public health surveillance program on neurological conditions. Engaging in epidemiology, surveillance science, and public health decision-making.
đşđ¸ United States â Remote
đľ $89k - $148k / year
đ° Grant on 2023-02
â° Full Time
đ Senior
⨠Scientist
đŚ H1B Visa Sponsor
đ 3 days ago
Senior Fisheries Management Scientist providing scientific analysis and regulatory support for salmon harvest programs. Collaborating on fishery management in the Pacific Northwest and California.
đ 4 days ago
Field Applications Scientist providing sales and customer support for revolutionary immunoassay platforms. Engaging in pre-sales support and customer training while fostering relationships in New York territory.
đşđ¸ United States â Remote
đľ $85.6k - $140.8k / year
â° Full Time
đĄ Mid-level
đ Senior
⨠Scientist
đ 5 days ago
Senior Bioinformatics Scientist at Veracyte driving next-generation MRD test development. Collaborating with cross-functional teams for robust clinical diagnostics delivery.
đ 6 days ago
Scientist/Sr. Scientist in Oligonucleotide Chemistry leading oligonucleotide discovery programs. Collaborate with cross-functional teams for therapeutic oligonucleotides development.